-
1
-
-
0023850473
-
Recombinant human erythropoietin: Implications for nephrology
-
Escbach JW, Adamson JW. Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis 1988; 11: 203-209
-
(1988)
Am J Kidney Dis
, vol.11
, pp. 203-209
-
-
Escbach, J.W.1
Adamson, J.W.2
-
2
-
-
0026349460
-
Treatment of transfusion-dependent anemia of chronic renal failure with recombinant human erythropoietin: A European multicenter study in 142 patients to define dose regimen and safety profile
-
Sundal E, Businger J, Kappeler A. Treatment of transfusion-dependent anemia of chronic renal failure with recombinant human erythropoietin: a European multicenter study in 142 patients to define dose regimen and safety profile. Nephrol Dial Transplant 1991; 6: 955-965
-
(1991)
Nephrol Dial Transplant
, vol.6
, pp. 955-965
-
-
Sundal, E.1
Businger, J.2
Kappeler, A.3
-
3
-
-
0030921662
-
NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
-
Escbach JW, DeOreo P, Adamson J et al. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30 [Suppl 3]: S192-S240
-
(1997)
Am J Kidney Dis
, vol.30
, Issue.SUPPL. 3
-
-
Escbach, J.W.1
DeOreo, P.2
Adamson, J.3
-
4
-
-
0031957274
-
Meeting the challenges of a new millennium: Optimizing the use of recombinant human erythropoietin
-
Macdougall IC. Meeting the challenges of a new millennium: optimizing the use of recombinant human erythropoietin. Nephrol Dial Transplant 1998; 13 [Suppl 2]: 23-27
-
(1998)
Nephrol Dial Transplant
, vol.13
, Issue.SUPPL. 2
, pp. 23-27
-
-
Macdougall, I.C.1
-
5
-
-
0024394986
-
Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease
-
Silberberg JS, Rahal DP, Patton DR, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 1989; 64: 222-224
-
(1989)
Am J Cardiol
, vol.64
, pp. 222-224
-
-
Silberberg, J.S.1
Rahal, D.P.2
Patton, D.R.3
Sniderman, A.D.4
-
6
-
-
0027949369
-
Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure
-
Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe N. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 1994; 24: 768-776
-
(1994)
Am J Kidney Dis
, vol.24
, pp. 768-776
-
-
Greaves, S.C.1
Gamble, G.D.2
Collins, J.F.3
Whalley, G.A.4
Sharpe, N.5
-
7
-
-
10244247846
-
Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients
-
Ertürk Ş, Ertuǧ AE, Ateş K et al. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 2050-2054
-
(1996)
Nephrol Dial Transplant
, vol.11
, pp. 2050-2054
-
-
Ertürk, Ş.1
Ertuǧ, A.E.2
Ateş, K.3
-
8
-
-
0027933131
-
Insulin-like growth factor-I and cardiac mass in essential hypertension: Comparative effects of captopril, lisinopril, and quinalapril
-
Diez J, Laviades C. Insulin-like growth factor-I and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril, and quinalapril. J Hypertens 1994; 12 [Suppl]: S31-S36
-
(1994)
J Hypertens
, vol.12
, Issue.SUPPL.
-
-
Diez, J.1
Laviades, C.2
-
9
-
-
0030474233
-
Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed doppler echocardiographic studies
-
Sasaki M, Oki T, Iuchi A et al. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed doppler echocardiographic studies. J Hypertens 1996; 12: 1403-1408
-
(1996)
J Hypertens
, vol.12
, pp. 1403-1408
-
-
Sasaki, M.1
Oki, T.2
Iuchi, A.3
-
10
-
-
0030981574
-
ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure
-
Dyadyk AI, Bagriy AE, Lebed IA, Yarovaya NF, Schukina EV, Taradin GG. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure. Nephrol Dial Transplant 1997; 12: 945-951
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 945-951
-
-
Dyadyk, A.I.1
Bagriy, A.E.2
Lebed, I.A.3
Yarovaya, N.F.4
Schukina, E.V.5
Taradin, G.G.6
-
11
-
-
0030725787
-
Prolong therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects
-
Cannella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S. Prolong therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 1997; 30: 659-664
-
(1997)
Am J Kidney Dis
, vol.30
, pp. 659-664
-
-
Cannella, G.1
Paoletti, E.2
Delfino, R.3
Peloso, G.4
Rolla, D.5
Molinari, S.6
-
12
-
-
0345586746
-
Therapeutic efficacy and tolerance of two orally active angiotensin converting enzyme inhibitors in patients undergoing regular hemodialysis
-
Abstract
-
Sennesael J, Verbeelen D. Therapeutic efficacy and tolerance of two orally active angiotensin converting enzyme inhibitors in patients undergoing regular hemodialysis. Kidney Int 1985; 28: A252 [Abstract]
-
(1985)
Kidney Int
, vol.28
-
-
Sennesael, J.1
Verbeelen, D.2
-
13
-
-
0025309116
-
Effect of angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats
-
Gould AB, Goodman SA. Effect of angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats. Eur J Pharmacol 1990; 181: 225-234
-
(1990)
Eur J Pharmacol
, vol.181
, pp. 225-234
-
-
Gould, A.B.1
Goodman, S.A.2
-
14
-
-
0022541637
-
Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients
-
Hirakata H, Onoyama K, Hori K, Fujishima M. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients. Clin Nephrol 1986; 26: 27-32
-
(1986)
Clin Nephrol
, vol.26
, pp. 27-32
-
-
Hirakata, H.1
Onoyama, K.2
Hori, K.3
Fujishima, M.4
-
16
-
-
0029819150
-
Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
-
Cruz DN, Perazella MA, Abu-Alfa AK, Mahnensmith RL. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance? Am J Kidney Dis 1996; 28: 535-540
-
(1996)
Am J Kidney Dis
, vol.28
, pp. 535-540
-
-
Cruz, D.N.1
Perazella, M.A.2
Abu-Alfa, A.K.3
Mahnensmith, R.L.4
-
17
-
-
0031971365
-
Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis
-
Schwenk MH, Jumani AQ, Rosenberg CR, Kulogowski JE, Charytan C, Spinowitz BS. Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis. Pharmacotherapy 1998; 18: 627-630
-
(1998)
Pharmacotherapy
, vol.18
, pp. 627-630
-
-
Schwenk, M.H.1
Jumani, A.Q.2
Rosenberg, C.R.3
Kulogowski, J.E.4
Charytan, C.5
Spinowitz, B.S.6
-
18
-
-
0030033358
-
Unresponsiveness to recombinant human erythropoietin in haemodialysis patients. Possible implications of angiotensin converting enzyme inhibitors
-
Ertürk Ş, Ateş K, Duman N, Karatan O, Erbay B, Ertuǧ E. Unresponsiveness to recombinant human erythropoietin in haemodialysis patients. Possible implications of angiotensin converting enzyme inhibitors. Nephrol Dial Transplant 1996; 11: 396-397
-
(1996)
Nephrol Dial Transplant
, vol.11
, pp. 396-397
-
-
Ertürk, Ş.1
Ateş, K.2
Duman, N.3
Karatan, O.4
Erbay, B.5
Ertuǧ, E.6
-
19
-
-
0031970298
-
High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients
-
Albitar S, Genin R, Fen-Chong M, Serveaux M-O, Bourgeon B. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 1206-1210
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 1206-1210
-
-
Albitar, S.1
Genin, R.2
Fen-Chong, M.3
Serveaux, M.-O.4
Bourgeon, B.5
-
20
-
-
0027688501
-
Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error
-
Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213
-
(1993)
J Am Soc Nephrol
, vol.4
, pp. 1205-1213
-
-
Daugirdas, J.T.1
-
21
-
-
0018231715
-
Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-Mode echocardiography. Results of a survey of echocardiographic measurements
-
Sahn DJ, De Maria A, Kisslo J, Weyman A. Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-Mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083
-
(1978)
Circulation
, vol.58
, pp. 1072-1083
-
-
Sahn, D.J.1
De Maria, A.2
Kisslo, J.3
Weyman, A.4
-
22
-
-
0022588019
-
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
-
Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458
-
(1986)
Am J Cardiol
, vol.57
, pp. 450-458
-
-
Devereux, R.B.1
Alonso, D.R.2
Lutas, E.M.3
-
23
-
-
0025357286
-
Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
-
Silberberg J, Racine N, Barre P, Sniderman AD. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 1990; 6: 1-4
-
(1990)
Can J Cardiol
, vol.6
, pp. 1-4
-
-
Silberberg, J.1
Racine, N.2
Barre, P.3
Sniderman, A.D.4
-
24
-
-
0345545516
-
Antihypertensive drugs
-
Brenner BM (ed). WB Saunders, Philadelphia
-
Bauer JH, Reams GP. Antihypertensive drugs. In: Brenner BM (ed). The Kidney. WB Saunders, Philadelphia; 1996: 2331-2381
-
(1996)
The Kidney
, pp. 2331-2381
-
-
Bauer, J.H.1
Reams, G.P.2
-
25
-
-
0023527675
-
Regression of cardiac hypertrophy: Experimental and clinical results
-
Motz W, Klepzig M, Strauer BE. Regression of cardiac hypertrophy: experimental and clinical results. J Cardiovasc Pharmacol 1987; 10 [Suppl 6]: S148-S152
-
(1987)
J Cardiovasc Pharmacol
, vol.10
, Issue.SUPPL. 6
-
-
Motz, W.1
Klepzig, M.2
Strauer, B.E.3
-
26
-
-
0014082125
-
Studies on erythropoietic action of angiotensin II
-
Nakao K, Shirakura T, Azuma M, Maekawa T. Studies on erythropoietic action of angiotensin II. Blood 1967; 29: 754-760
-
(1967)
Blood
, vol.29
, pp. 754-760
-
-
Nakao, K.1
Shirakura, T.2
Azuma, M.3
Maekawa, T.4
-
27
-
-
0019201808
-
Interrelation of the renin system and erythropoietin in rats
-
Gould AB, Goodman SA, DeWolf R, Onesti G, Swartz C. Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 1980; 96: 523-534
-
(1980)
J Lab Clin Med
, vol.96
, pp. 523-534
-
-
Gould, A.B.1
Goodman, S.A.2
DeWolf, R.3
Onesti, G.4
Swartz, C.5
-
28
-
-
0030671372
-
Angiotensin II stimulates proliferation of normal early erythroid progenitors
-
Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 1997; 100: 2310-2314
-
(1997)
J Clin Invest
, vol.100
, pp. 2310-2314
-
-
Mrug, M.1
Stopka, T.2
Julian, B.A.3
Prchal, J.F.4
Prchal, J.T.5
-
29
-
-
0031713501
-
Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats
-
Naeshiro I, Sato K, Chatani F, Sato S. Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats. Eur J Pharmacol 1998; 354: 179-187
-
(1998)
Eur J Pharmacol
, vol.354
, pp. 179-187
-
-
Naeshiro, I.1
Sato, K.2
Chatani, F.3
Sato, S.4
-
30
-
-
0029764132
-
Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients
-
Gossmann J, Thürmann P, Bachmann T et al. Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney Int 1996; 50: 973-978
-
(1996)
Kidney Int
, vol.50
, pp. 973-978
-
-
Gossmann, J.1
Thürmann, P.2
Bachmann, T.3
-
31
-
-
0031778819
-
Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis
-
Julian BA, Brantley RR Jr, Barker CV et al. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis. J Am Soc Nephrol 1998; 9: 1104-1108
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 1104-1108
-
-
Julian, B.A.1
Brantley R.R., Jr.2
Barker, C.V.3
-
32
-
-
0030880061
-
Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients
-
Morrone LF, Di Paolo S, Logoluso F et al. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients. Transplantation 1997; 64: 913-918
-
(1997)
Transplantation
, vol.64
, pp. 913-918
-
-
Morrone, L.F.1
Di Paolo, S.2
Logoluso, F.3
-
33
-
-
0031956444
-
Acute effect of trandolapril on serum erythropoietin in uremic and hypertensive patients
-
Akpolat T, Gümüş T, Bedir A, Adam B. Acute effect of trandolapril on serum erythropoietin in uremic and hypertensive patients. J Nephrol 1998; 11: 94-97
-
(1998)
J Nephrol
, vol.11
, pp. 94-97
-
-
Akpolat, T.1
Gümüş, T.2
Bedir, A.3
Adam, B.4
-
34
-
-
0031807166
-
Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells
-
Constantinescu CS, Goodman DB, Ventura ES. Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells. Immunol Lett 1998; 62: 25-31
-
(1998)
Immunol Lett
, vol.62
, pp. 25-31
-
-
Constantinescu, C.S.1
Goodman, D.B.2
Ventura, E.S.3
-
35
-
-
0024994966
-
Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy
-
Kamper A-L, Nielsen OJ. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 1990; 50: 611-618
-
(1990)
Scand J Clin Lab Invest
, vol.50
, pp. 611-618
-
-
Kamper, A.-L.1
Nielsen, O.J.2
-
36
-
-
0031693287
-
Effect of angiotensin-converting enzyme inhibitors on hematological parameters and recombinant human erythropoietin doses in peritoneal dialysis patients
-
Navarro JF, Mora C, Rivero A. Effect of angiotensin-converting enzyme inhibitors on hematological parameters and recombinant human erythropoietin doses in peritoneal dialysis patients. Nephron 1998; 80: 239
-
(1998)
Nephron
, vol.80
, pp. 239
-
-
Navarro, J.F.1
Mora, C.2
Rivero, A.3
-
37
-
-
0009676920
-
Interleukin-3 potentiates the effect of erythropoietin in a uraemic anaemic animal model
-
Macdougall IC, Allen DA, Cavill I, Baker LRI, Raine AEG. Interleukin-3 potentiates the effect of erythropoietin in a uraemic anaemic animal model. Nephrol Dial Transplant 1994; 9: 1032-1033
-
(1994)
Nephrol Dial Transplant
, vol.9
, pp. 1032-1033
-
-
Macdougall, I.C.1
Allen, D.A.2
Cavill, I.3
Baker, L.R.I.4
Raine, A.E.G.5
-
38
-
-
0031682119
-
Role of cytokines in the response to erythropoietin in hemodialysis patients
-
Goicoechea M, Martin J, De Sequera P et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 1998; 54: 1337-1343
-
(1998)
Kidney Int
, vol.54
, pp. 1337-1343
-
-
Goicoechea, M.1
Martin, J.2
De Sequera, P.3
|